News
A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...
While Patients Suffer, DEA Manipulates Due Process to Cover Its Cannabis Crimes. The DEA blocking federally compliant ...
4d
News-Medical.Net on MSNEgr-1 gene identified as crucial regulator of regulatory T cells in multiple sclerosisAutoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...
Neural stem cell treatment was safe and significantly boosted myelin repair in spinal cord lesions in a mouse model of MS, ...
Blood tests could pave the way for distinguishing between Alzheimer’s, Parkinson’s and some dementias, aiding early treatment for brain diseases.
New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies.
See the latest Axon Enterprise Inc stock price (AXON:XMEX), related news, valuation, dividends and more to help you make your investing decisions.
In a landmark discovery, researchers from QIMR Berghofer in collaboration with the Francis Crick Institute, have unlocked the ...
Mirima Freimer, MD, delves into potential reasons behind the longer-term efficacy of zilucoplan and also speaks to the treatment’s safety profile.
Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results